Carfilzomib | High-Quality Pharmaceutical Reference Standard
Carfilzomib API is a selective proteasome inhibitor used in the treatment of relapsed or refractory multiple myeloma. It induces apoptosis in cancer cells by disrupting protein degradation pathways and is manufactured under GMP standards for injectable formulations.
Carfilzomib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 5
